Movement Disorders

Challenges associated with advances in the genetics of movement disorders 2:19
Challenges associated with advances in the genetics of movement disorders
Kailash Bhatia • 30 Sep 2021
Defining the etiology of dystonia 1:51
Defining the etiology of dystonia
Kailash Bhatia • 30 Sep 2021
Gut dysbiosis in Parkinson’s disease 1:02
Gut dysbiosis in Parkinson’s disease
Brit Mollenhauer • 24 Sep 2021
Microbiome to elucidate Parkinson’s disease 4:41
Microbiome to elucidate Parkinson’s disease
Paul Wilmes • 5 Oct 2021
Genetic and phenotypic heterogeneity in dystonia 3:02
Genetic and phenotypic heterogeneity in dystonia
Kailash Bhatia • 30 Sep 2021
Nutritional intervention studies to influence the gut microbiome and improve Parkinson’s disease 3:10
Nutritional intervention studies to influence the gut microbiome and improve Parkinson’s disease
Brit Mollenhauer • 24 Sep 2021
New research looking into disease modifying treatments for atypical parkinsonism 2:32
New research looking into disease modifying treatments for atypical parkinsonism
Irene Litvan • 22 Sep 2021
How does exercise slow progression in Parkinson’s disease? 1:56
How does exercise slow progression in Parkinson’s disease?
Daniel Corcos • 23 Sep 2021
Movement disorders: is searching for a cure hindering the development of symptomatic treatments? 2:16
Movement disorders: is searching for a cure hindering the development of symptomatic treatments?
Alfonso Fasano • 22 Sep 2021
Phase III SPARX3 trial of moderate- vs. high-intensity exercise to slow progression in PD 4:37
Phase III SPARX3 trial of moderate- vs. high-intensity exercise to slow progression in PD
Daniel Corcos • 23 Sep 2021
The future of neuromodulation strategies in movement disorders 1:43
The future of neuromodulation strategies in movement disorders
Andrea Kühn • 7 Sep 2021
Advances in the diagnosis of atypical parkinsonism 3:58
Advances in the diagnosis of atypical parkinsonism
Irene Litvan • 22 Sep 2021
The future of imaging in Parkinson’s disease 1:51
The future of imaging in Parkinson’s disease
Sofia Reimão • 20 Sep 2021
The impact of LCIG on dyskinesia duration & severity in PD 4:19
The impact of LCIG on dyskinesia duration & severity in PD
Alfonso Fasano • 22 Sep 2021
Developments in DBS at MDS 2021 1:59
Developments in DBS at MDS 2021
Andrea Kühn • 7 Sep 2021
Genetic testing for Parkinson’s disease in clinical practice 2:27
Genetic testing for Parkinson’s disease in clinical practice
Oscar Gershanik • 16 Sep 2021
The content of VJNeurology is intended for healthcare professionals